Latest Breaking News On - Immunorizon ltd - Page 1 : comparemela.com

Purple Biotech : Immediate report on other matter -October 30, 2023 at 05:04 pm EDT

As filed with the Securities and Exchange Commission on October 30, 2023 Registration No. 333- UNITED STATES .

United statesDistrict of columbiaTel aviv yafoTel avivGaza stripNew yorkState of israelRicka wernerRockefeller plazaJayun kooSharon rosenLior fhimaHc wainwright coBristol myers squibbTel aviv stock exchangeDrug administration

Purple Biotech : Other Report or Announcement -October 19, 2023 at 01:21 pm EDT

Submission Data File General Information .

United statesTel avivState of israelPurple biotech ltdTel aviv stock exchangeBristol myers squibbHc wainwright coExchange commissionCompany nameKitov pharmaceuticalsImmunorizon ltdEdgar agentsFamewave ltdDrug administrationForeign investment companyTyrnovo ltd

Form 424B5 PURPLE BIOTECH LTD

Form 424B5 PURPLE BIOTECH LTD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tel avivGaza stripIsrael generalTel aviv districtDistrict of columbiaUnited statesNew yorkState of israelImmunorizon adssSomekh chaikinIsrael securities authority magnaDrug administrationIsrael tax authorityInternational conference of harmonizationEuropean unionIsraeli registrar of companies

Purple Biotech Ltd : Purple Biotech Reports First Quarter 2023 Financial Results and Provides Business Update

Expands pipeline with acquisition of new tri-specific antibodiesData readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, May 16, 2023 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple

United statesGewinn nurLior fhimaHarriet ullmanExchange commissionProduct communicationsUniversity of texas md anderson cancer centerDrug administrationDevelopment expensesBristol myers squibbOwners of the companyCompany contactPurple biotech ltdAmerican association for cancer researchImmunorizon acquisition expands company pipelineInternational financial reporting standards

Purple Biotech Reports New Preclinical Data on Potential of NT219 to Re-sensitize Resistant Tumors to Immune Checkpoint Inhibitors

Purple Biotech Reports New Preclinical Data on Potential of NT219 to Re-sensitize Resistant Tumors to Immune Checkpoint Inhibitors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHarriet ullmanviceHadas reuveniImmunorizon ltdProduct communications lavoiehealthscienceBristol myers squibbPurple biotech ltdAmerican association for cancer researchExchange commissionDrug administrationUniversity of texas md anderson cancer centerAmerican associationCancer researchAnnual meetingImmune checkpoint blockagePurple biotech website